WJ R&D Center, WOOJUNG BSC, Advanced Institutes of Convergence Technology, 145 Gwanggyo-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do, 443-270, Republic of Korea.
Applied Biotechnology Department, Ajou University, 206 Worldcup-ro, Yeongtong-gu, Suwon, 16499, Republic of Korea.
Breast Cancer. 2018 Sep;25(5):529-538. doi: 10.1007/s12282-018-0849-5. Epub 2018 Mar 7.
The E3 ubiquitin ligase constitutive photomorphogenic 1 (COP1) mediates cell survival, growth, and development, and interacts with the tumor suppressor protein p53 to induce its ubiquitination and degradation. Recent studies reported that COP1 overexpression is associated with increased cell proliferation, transformation, and disease progression in a variety of cancer types. In this study, we investigated whether COP1 regulates p53-mediated cell cycle arrest and apoptosis in human breast cancer cell lines.
We downregulated COP1 expression using lentiviral particles expressing short hairpin RNA (shRNA) targeting COP1 and measured the effects of the knockdown in three different breast cancer cell lines.
COP1 silencing resulted in p53 activation, which induced the expression of p21 and p53-upregulated modulator of apoptosis (PUMA) expression, and reduced the levels of cyclin-dependent kinase 2 (CDK2). Notably, knockdown of COP1 was associated with cell cycle arrest during the G/G phase.
The COP1-mediated degradation of p53 regulates cancer cell growth and apoptosis. Our results indicate that COP1 regulates human breast cancer cell proliferation and apoptosis in a p53-dependent manner. These findings suggest that COP1 might be a promising potential target for breast cancer-related gene therapy.
E3 泛素连接酶组成性光形态发生 1(COP1)介导细胞存活、生长和发育,并与肿瘤抑制蛋白 p53 相互作用,诱导其泛素化和降解。最近的研究表明,COP1 的过表达与多种癌症类型中细胞增殖、转化和疾病进展的增加有关。在本研究中,我们研究了 COP1 是否调节人乳腺癌细胞系中 p53 介导的细胞周期停滞和细胞凋亡。
我们使用靶向 COP1 的短发夹 RNA(shRNA)的慢病毒颗粒下调 COP1 的表达,并在三种不同的乳腺癌细胞系中测量敲低的效果。
COP1 沉默导致 p53 激活,诱导 p21 和 p53 上调凋亡调节剂(PUMA)的表达,并降低细胞周期蛋白依赖性激酶 2(CDK2)的水平。值得注意的是,COP1 的敲低与 G1/G0 期的细胞周期停滞有关。
COP1 介导的 p53 降解调节癌细胞的生长和凋亡。我们的结果表明,COP1 以 p53 依赖的方式调节人乳腺癌细胞的增殖和凋亡。这些发现表明,COP1 可能是乳腺癌相关基因治疗的一个有前途的潜在靶点。